| Ticker Details |
|
Cogent Biosciences, Inc.
|
| IPO Date: |
March 26, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$5.73B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.31 | 3.14%
|
| Avg Daily Range (30 D): |
$0.87 | 2.33%
|
| Avg Daily Range (90 D): |
$0.81 | 2.52%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.7M |
| Avg Daily Volume (30 D): |
1.68M |
| Avg Daily Volume (90 D): |
2.47M |
| Trade Size |
| Avg Trade Size (Sh.): |
103 |
| Avg Trade Size (Sh.) (30 D): |
69 |
| Avg Trade Size (Sh.) (90 D): |
80 |
| Institutional Trades |
| Total Institutional Trades: |
2,534 |
| Avg Institutional Trade: |
$2M |
| Avg Institutional Trade (30 D): |
$3.32M |
| Avg Institutional Trade (90 D): |
$2.77M |
| Avg Institutional Trade Volume: |
.15M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.75M |
| Avg Closing Trade (30 D): |
$8.37M |
| Avg Closing Trade (90 D): |
$10.59M |
| Avg Closing Volume: |
206.52K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-2.16
|
$-.61
|
$-2.16
|
|
Diluted EPS
|
$-2.16
|
$-.61
|
$-2.16
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-328.94M
|
$-102.49M
|
$-328.94M
|
|
Operating Income / Loss
|
$-333.36M
|
$-99.49M
|
$-333.36M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$214.26M
|
$186.8M
|
$214.26M
|
|
PE Ratio
|
|
|
|
|
|
|